PCI starts work on another expansion

PCI is adding potent handling capabilities at its site in the U.K. (PCI Pharma Services)

Having only just completed an expansion of its clinical supply facility in Illinois, PCI Pharma Services will now expand its solid dose facility in Wales in the U.K. 

Philadelphia-based PCI says it is doubling the large-scale granulation and fluid bed drying capacity at the Wales facility. It also is adding space for new potent handling capabilities as well as areas for additional analytical and small-scale processing that will permit it to do early-stage, non-GMP processing and formulation. 

RELATED: PCI debuts expansion of its Rockford, Illinois, facility

It expects the expansion to be complete in 2021. It did not disclose its investment. 

The work in the U.K. follows completion of a 30,000-square-foot expansion of PCI's facility in Rockford, Illinois, where it added primary and secondary packaging as well as labeling for clinical supplies. It also included a temperature-controlled suite

Earlier in the year, the company said it would add a 75,000-square-foot clinical supply facility near Dublin that can handle both primary and secondary packaging, storage, logistics and distribution.

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.